v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   104,880,000      
Beginning balance at Dec. 31, 2024 $ 192,981 $ 105 $ 1,114,550 $ (32,233) $ (889,441)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net share settlement of equity awards (in shares)   497,000      
Net share settlement of equity awards (469)   (469)    
Share-based compensation expense 11,657   11,657    
Other comprehensive loss (1,014)     (1,014)  
Net income (loss) (17,484)       (17,484)
Ending balance (in shares) at Mar. 31, 2025   105,377,000      
Ending balance at Mar. 31, 2025 $ 185,671 $ 105 1,125,738 (33,247) (906,925)
Beginning balance (in shares) at Dec. 31, 2025 110,985,562 110,986,000      
Beginning balance at Dec. 31, 2025 $ 119,623 $ 111 1,145,371 (32,997) (992,862)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net share settlement of equity awards (in shares)   856,000      
Net share settlement of equity awards (596) $ 1 (597)    
Share-based compensation expense 2,812   2,812    
Other comprehensive loss (924)     (924)  
Net income (loss) $ 228       228
Ending balance (in shares) at Mar. 31, 2026 111,841,854 111,842,000      
Ending balance at Mar. 31, 2026 $ 121,143 $ 112 $ 1,147,586 $ (33,921) $ (992,634)